在与全身性硬化症相关的腹腔肺部疾病中,在任泰达尼布治疗下,出现复发性自发性肺胸病
Abdurrahman Soner Şenel1, Tuğba Kahraman Denizhan2, Melih Kızıltepe3
1Department of Erciyes University of Rheumatology /Internal medicine Kayseri, Turkey. drsonersenel@gmail.com.
丁丁达尼布治疗系统性硬化症相关的间歇性肺病 (SSc-ILD). 然而,这种抗纤维性药物可能会增加患肺胸部风险,需要对患者进行仔细监测.
科学领域:
- 肺部病理学 肺部病理学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 间歇性肺病 (ILD) 是系统性硬化症 (SSc) 的常见并发症.
- 宁达达尼布是一种已批准用于SSc-ILD的抗纤维菌药物.
- 关于肺胸炎风险的宁泰达尼布的安全概况尚未完全确定.
研究的目的:
- 报告一个患有SSc-ILD,接受任天达尼布治疗的患者的复发性肺胸病例.
- 突出尼丁达尼布与耐火性肺胸部之间的潜在关联.
主要方法:
- 一个患有系统性硬化症相关的间歇性肺病的病人的病例报告.
- 在任丁达尼布治疗期间观察肺胸部发育.
主要成果:
- 患者在接受宁泰达尼布治疗期间出现了复发性,耐治疗的肺胸部.
- 这表明任天达尼布与肺胸部发育之间存在潜在的联系.
结论:
- 在SSc-ILD患者中,丁丁达尼布治疗可能与肺胸部风险增加有关.
- 密切监测肺胸部对于SSc患者开始忍丹尼布治疗至关重要.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
相关概念视频
Pneumothorax-II
Clinical Manifestations:
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Other Pulmonary Disorders
Pulmonary Cycle: Exhalation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
